# Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery

> **NCT04029467** · PHASE4 · UNKNOWN · sponsor: **Lebanese American University** · enrollment: 44 (estimated)

## Conditions studied

- Breast Cancer
- Mastectomy
- Axillary Lymph Node Dissection
- Pain, Postoperative

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT04029467
- **Lead sponsor:** Lebanese American University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-17
- **Primary completion:** 2021-07-17
- **Final completion:** 2022-01-17
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04029467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04029467, "Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04029467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*